P4HA2 and cervical carcinoma: Studies have revealed that P4HA2 upregulates the expression of PD-L1 in cervical cancer tissues and is negatively correlated with CD8+ T cells, regulating antitumor immunity and serving as a prognostic marker for immunotherapy (46).